{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:40:04Z","timestamp":1792021204183,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Arthritis Society Canada","award":["SOG-18-0192"],"award-info":[{"award-number":["SOG-18-0192"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Describe patterns of pharmacotherapy and psychological treatment and evaluate receipt of minimally adequate treatment for incident depression and anxiety in individuals with inflammatory arthritis (IA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We used population-based linked administrative health databases from British Columbia, Canada to evaluate pharmacotherapy and psychological treatments for incident depression and\/or anxiety among individuals with IA and without IA (\u2018IA-free controls\u2019). We defined minimally adequate pharmacotherapy as antidepressant prescriptions filled with \u2265\u200984 days\u2019 supply and adequate psychological treatment as \u2265\u20094 counselling\/psychotherapy services. Multivariable logistic regression models were used to evaluate the odds of individuals with IA receiving minimally adequate pharmacotherapy and\/or psychological treatment compared to IA-free controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>6,951 (mean age 54.8\u2009\u00b1\u200918.3 years; 65.5% female) individuals with IA had incident depression and 3,701 (mean age 52.9\u2009\u00b1\u200916.8 years; 74.3% female) had incident anxiety. Minimally adequate pharmacotherapy and psychological treatment for depression was respectively observed in 50.5% and 19.6% of those with IA, proportions similar to IA-free controls (pharmacotherapy: aOR 1.10, 95% CI 1.00 to 1.21; psychological: aOR 1.07, 95% CI 0.94 to 1.21). Results were similar regarding anxiety treatment. Individuals with IA had a significantly greater likelihood of dispensing\u2009\u2265\u20091 benzodiazepine (anxiety: IA 45.0%, IA-free controls 39.0%, p-value\u2009&lt;\u20090.001) and \u2265\u20091 tricyclic antidepressant prescription (anxiety: IA 12.8%, IA-free controls 7.8%, p-value\u2009&lt;\u20090.001). Significantly higher average days\u2019 supply of benzodiazepines was observed for IA (anxiety: IA 123.7 days, controls 112.4 days, p-value\u2009=\u20090.003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A substantial proportion of individuals with IA were not receiving adequate mental health treatment for depression and anxiety, a finding similar for IA-free controls. The undertreatment of mental disorders for people with IA has well-known negative implications for the provision of effective rheumatology care. It remains fundamental to expand publicly funded health care to include mental health services in an effort to address unmet counselling needs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13075-024-03466-8","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:15:17Z","timestamp":1737436517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study"],"prefix":"10.1186","volume":"27","author":[{"given":"Alyssa","family":"Howren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Sayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Antonio","family":"Avina-Zubieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Puyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"De Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"3","key":"3466_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3899\/jrheum.150388","volume":"43","author":"CC Shen","year":"2016","unstructured":"Shen CC, Hu LY, Yang AC, Kuo BI, Chiang YY, Tsai SJ. Risk of Psychiatric disorders following Ankylosing spondylitis: a Nationwide Population-based Retrospective Cohort Study. J Rheumatol. 2016;43(3):625\u201331.","journal-title":"J Rheumatol"},{"key":"3466_CR2","doi-asserted-by":"crossref","unstructured":"Kaine J, Song X, Kim G, Hur P, Palmer JB. Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the General Population using U.S. administrative Claims Data. J Manag Care Spec Pharm. 2018:1\u201311.","DOI":"10.18553\/jmcp.2018.17421"},{"issue":"7","key":"3466_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/acr.23539","volume":"70","author":"RA Marrie","year":"2018","unstructured":"Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased Burden of Psychiatric disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018;70(7):970\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"3466_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/rheumatology\/kez559","volume":"59","author":"SY Kim","year":"2020","unstructured":"Kim SY, Chanyang M, Oh DJ, Choi HG. Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort. Rheumatology (Oxford). 2020;59(8):1889\u201397.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3466_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/13696998.2019.1572015","volume":"22","author":"N Li","year":"2019","unstructured":"Li N, Chan E, Peterson S. The economic burden of depression among adults with rheumatoid arthritis in the United States. J Med Econ. 2019;22(4):372\u20138.","journal-title":"J Med Econ"},{"issue":"10","key":"3466_CR6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/rheumatology\/kes356","volume":"52","author":"AM Rathbun","year":"2013","unstructured":"Rathbun AM, Reed GW, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology (Oxford). 2013;52(10):1785\u201394.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3466_CR7","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3899\/jrheum.100050","volume":"37","author":"DL Mattey","year":"2010","unstructured":"Mattey DL, Dawes PT, Hassell AB, Brownfield A, Packham JC. Effect of psychological distress on continuation of anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. J Rheumatol. 2010;37(10):2021\u20134.","journal-title":"J Rheumatol"},{"issue":"8","key":"3466_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","volume":"18","author":"LC Coates","year":"2022","unstructured":"Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465\u201379.","journal-title":"Nat Rev Rheumatol"},{"key":"3466_CR9","unstructured":"National Institute for Health and Care Excellence. Rheumatoid arthritis in adults: management (NICE guideline NG100) 2018 [Available from: https:\/\/www.nice.org.uk\/guidance\/ng100.]."},{"issue":"3","key":"3466_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10067-014-2677-0","volume":"35","author":"P Anyfanti","year":"2016","unstructured":"Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S, et al. Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated. Clin Rheumatol. 2016;35(3):733\u20139.","journal-title":"Clin Rheumatol"},{"key":"3466_CR11","unstructured":"Canadian Institute for Health Information [creator]. (2019): Discharge Abstract Database (Hospital Separations). V2. Population Data BC [publisher]. Data Extract. MOH (2019) http:\/\/www.popdata.bc.ca\/data"},{"key":"3466_CR12","unstructured":"British Columbia Ministry of Health [creator]. (2018):. Medical Services Plan (MSP) Payment Information File. Population Data BC [publisher]. Data Extract. MOH (2019). http:\/\/www.popdata.bc.ca\/data"},{"key":"3466_CR13","unstructured":"British Columbia Ministry of Health [creator]. (2018): Vital Events Deaths. Population Data BC [publisher]. Data Extract. MOH (2018). http:\/\/www.popdata.bc.ca\/data"},{"key":"3466_CR14","unstructured":"British Columbia Ministry of Health [creator]. (2019): Consolidation File (MSP Registration & Premium Billing). Population Data BC [publisher]. Data Extract. MOH (2019). http:\/\/www.popdata.bc.ca\/data"},{"key":"3466_CR15","unstructured":"British Columbia Ministry of Health [creator]. (2019): PharmaNet. V2. BC Ministry of Health [publisher]. Data Extract. Data Stewardship Committee (2019). http:\/\/www.popdata.bc.ca\/data"},{"issue":"4","key":"3466_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2018-214388","volume":"78","author":"JA Avi\u00f1a-Zubieta","year":"2019","unstructured":"Avi\u00f1a-Zubieta JA, Chan J, De Vera M, Sayre EC, Choi H, Esdaile J. Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study. Ann Rheum Dis. 2019;78(4):480\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3466_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/pds.4950","volume":"29","author":"H Lee","year":"2020","unstructured":"Lee H, Ford JA, Jin Y, Cho SK, Santiago Ortiz AJ, Tong AY, et al. Validation of claims-based algorithms for psoriatic arthritis. Pharmacoepidemiol Drug Saf. 2020;29(4):404\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl","key":"3466_CR18","first-page":"S49","volume":"63","author":"J Chang","year":"2011","unstructured":"Chang J, Rogers P, Lacaille D. Can American College of Rheumatology criteria for rheumatoid arthritis be assessed using self-report data? \u2013 comparison of self-reported data with chart review. Arthritis Rheum. 2011;63(Suppl):S49.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3466_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2016-209562","volume":"76","author":"D Lacaille","year":"2017","unstructured":"Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis. 2017;76(6):1057\u201363.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3466_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12888-018-1990-6","volume":"19","author":"C Doktorchik","year":"2019","unstructured":"Doktorchik C, Patten S, Eastwood C, Peng M, Chen G, Beck CA, et al. Validation of a case definition for depression in administrative data against primary chart data as a reference standard. BMC Psychiatry. 2019;19(1):9.","journal-title":"BMC Psychiatry"},{"key":"3466_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2377-13-16","volume":"13","author":"RA Marrie","year":"2013","unstructured":"Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol. 2013;13:16.","journal-title":"BMC Neurol"},{"key":"3466_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychores.2016.08.014","volume":"89","author":"RA Marrie","year":"2016","unstructured":"Marrie RA, Walker JR, Graff LA, Lix LM, Bolton JM, Nugent Z, et al. Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease. J Psychosom Res. 2016;89:107\u201313.","journal-title":"J Psychosom Res"},{"key":"3466_CR23","unstructured":"Medical Services Commission (MSC) Payment Schedule Index [Internet]. 2015. Available from: https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/practitioner-pro\/medical-services-plan\/msc_payment_schedule.pdf"},{"issue":"9","key":"3466_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Sect.\u00a03. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540\u201360.","journal-title":"Can J Psychiatry"},{"issue":"7","key":"3466_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/0706743716640288","volume":"61","author":"JH Puyat","year":"2016","unstructured":"Puyat JH, Kazanjian A, Goldner EM, Wong H. How often do individuals with Major Depression receive minimally adequate treatment? A Population-Based, data linkage study. Can J Psychiatry. 2016;61(7):394\u2013404.","journal-title":"Can J Psychiatry"},{"issue":"9","key":"3466_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/0706743716659416","volume":"61","author":"RW Lam","year":"2016","unstructured":"Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, et al. Canadian Network for Mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Sect.\u00a01. Disease Burden and principles of Care. Can J Psychiatry. 2016;61(9):510\u201323.","journal-title":"Can J Psychiatry"},{"issue":"Suppl 1","key":"3466_CR27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","volume":"14","author":"MA Katzman","year":"2014","unstructured":"Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1.","journal-title":"BMC Psychiatry"},{"key":"3466_CR28","doi-asserted-by":"crossref","unstructured":"Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075\u20139. discussion 81-90.","DOI":"10.1016\/0895-4356(93)90103-8"},{"issue":"9","key":"3466_CR29","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/acr.24593","volume":"74","author":"A Wong","year":"2022","unstructured":"Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and anxiety reduce the probability of achieving a state of sustained minimal Disease activity in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2022;74(9):1430\u20134.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"3466_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/rheumatology\/kev306","volume":"55","author":"F Matcham","year":"2016","unstructured":"Matcham F, Norton S, Scott DL, Steer S, Hotopf M. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial. Rheumatology (Oxford). 2016;55(2):268\u201378.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3466_CR31","first-page":"1013","volume":"32","author":"DC Ang","year":"2005","unstructured":"Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32(6):1013\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"3466_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1136\/annrheumdis-2017-212867","volume":"78","author":"AC Boer","year":"2019","unstructured":"Boer AC, Huizinga TWJ, van der Helm-van Mil AHM. Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis. Ann Rheum Dis. 2019;78(1):e1.","journal-title":"Ann Rheum Dis"},{"key":"3466_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.genhosppsych.2018.06.001","volume":"53","author":"RA Marrie","year":"2018","unstructured":"Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, et al. Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. Gen Hosp Psychiatry. 2018;53:65\u201372.","journal-title":"Gen Hosp Psychiatry"},{"key":"3466_CR34","doi-asserted-by":"crossref","unstructured":"Puyat JH, Kazanjian A, Wong H, Goldner E. Comorbid Chronic General Health Conditions and Depression Care: A Population-Based Analysis. Psychiatr Serv. (Washington, DC). 2017;68(9):907\u2009\u2013\u200915.","DOI":"10.1176\/appi.ps.201600309"},{"key":"3466_CR35","doi-asserted-by":"publisher","first-page":"100385","DOI":"10.1016\/j.invent.2021.100385","volume":"24","author":"C Blaney","year":"2021","unstructured":"Blaney C, Hitchon CA, Marrie RA, Mackenzie C, Holens P, El-Gabalawy R. Support for a non-therapist assisted, internet-based cognitive-behavioral therapy (iCBT) intervention for mental health in rheumatoid arthritis patients. Internet Interv. 2021;24:100385.","journal-title":"Internet Interv"},{"key":"3466_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cpr.2016.09.002","volume":"49","author":"ZE Seidler","year":"2016","unstructured":"Seidler ZE, Dawes AJ, Rice SM, Oliffe JL, Dhillon HM. The role of masculinity in men\u2019s help-seeking for depression: a systematic review. Clin Psychol Rev. 2016;49:106\u201318.","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"3466_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.7326\/M22-1900","volume":"176","author":"L Affengruber","year":"2023","unstructured":"Affengruber L, Wagner G, Dobrescu A, Toromanova A, Chapman A, Persad E, et al. Values and preferences of patients with depressive disorders regarding pharmacologic and nonpharmacologic treatments: a Rapid Review. Ann Intern Med. 2023;176(2):217\u201323.","journal-title":"Ann Intern Med"},{"issue":"661","key":"3466_CR38","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.3399\/bjgp17X691877","volume":"67","author":"A Machin","year":"2017","unstructured":"Machin A, Hider S, Dale N, Chew-Graham C. Improving recognition of anxiety and depression in rheumatoid arthritis: a qualitative study in a community clinic. Br J Gen Pract. 2017;67(661):e531\u20137.","journal-title":"Br J Gen Pract"},{"issue":"20","key":"3466_CR39","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1001\/jama.2016.3445","volume":"315","author":"J Wong","year":"2016","unstructured":"Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006\u20132015. JAMA. 2016;315(20):2230\u20132.","journal-title":"JAMA"},{"issue":"12","key":"3466_CR40","doi-asserted-by":"publisher","first-page":"e041371","DOI":"10.1136\/bmjopen-2020-041371","volume":"10","author":"A Howren","year":"2020","unstructured":"Howren A, Avi\u00f1a-Zubieta JA, Da Costa D, Puyat JH, Xie H, De Vera MA. Impact of arthritis on the perceived need and use of mental healthcare among canadians with mental disorders: nationally representative cross-sectional study. BMJ Open. 2020;10(12):e041371.","journal-title":"BMJ Open"},{"key":"3466_CR41","unstructured":"Hu W. Diagnostic Codes in MSP Claim Data, Summary Report: Victoria: Medical Services Plan; 1996 [Available from: https:\/\/www.popdata.bc.ca\/sites\/default\/files\/documents\/data\/MSP%20Diagnostic%20Codes%20paper.pdf.]."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03466-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T17:05:18Z","timestamp":1737479118000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03466-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3466"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03466-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of British Columbia Behavioural Research Ethics Board (H18-03737).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}